Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 6:22 AM UTC
| NCT Number | NCT06122896 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 5,000 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | May 29, 2026 (May 29, 2026) |
As of August 29, 2026: Clinical trial NCT06122896 is currently recruiting participants. This early_phase1 study for pancreatic cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06122896 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06122896 was last updated May 29, 2026 (May 29, 2026). HelloStudys verifies this status automatically.